These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
322 related items for PubMed ID: 2720677
1. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells. Dale IL, Bradshaw TD, Gescher A, Pettit GR. Cancer Res; 1989 Jun 15; 49(12):3242-5. PubMed ID: 2720677 [Abstract] [Full Text] [Related]
2. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE. Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938 [Abstract] [Full Text] [Related]
3. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE. Cancer Res; 1992 Mar 01; 52(5):1278-83. PubMed ID: 1737390 [Abstract] [Full Text] [Related]
4. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells. Stanwell C, Gescher A, Bradshaw TD, Pettit GR. Int J Cancer; 1994 Feb 15; 56(4):585-92. PubMed ID: 8112895 [Abstract] [Full Text] [Related]
5. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway. Jalava A, Akerman K, Heikkilä J. J Cell Physiol; 1993 May 15; 155(2):301-12. PubMed ID: 8482723 [Abstract] [Full Text] [Related]
6. Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells. Dale IL, Gescher A. Int J Cancer; 1989 Jan 15; 43(1):158-63. PubMed ID: 2910827 [Abstract] [Full Text] [Related]
7. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1. Basu A, Lazo JS. Cancer Res; 1992 Jun 01; 52(11):3119-24. PubMed ID: 1591725 [Abstract] [Full Text] [Related]
8. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity. Levine BL, May WS, Tyler PG, Hess AD. J Immunol; 1991 Nov 15; 147(10):3474-81. PubMed ID: 1834742 [Abstract] [Full Text] [Related]
9. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM. Cancer Res; 1996 May 01; 56(9):2105-11. PubMed ID: 8616857 [Abstract] [Full Text] [Related]
10. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE. Clin Cancer Res; 1995 Dec 01; 1(12):1581-7. PubMed ID: 9815959 [Abstract] [Full Text] [Related]
11. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha. Clarke H, Ginanni N, Laughlin KV, Smith JB, Pettit GR, Mullin JM. Exp Cell Res; 2000 Nov 25; 261(1):239-49. PubMed ID: 11082294 [Abstract] [Full Text] [Related]
12. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis. Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD. Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972 [Abstract] [Full Text] [Related]
13. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation. Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM. Mol Pharmacol; 1994 Nov 10; 46(5):840-50. PubMed ID: 7969070 [Abstract] [Full Text] [Related]
14. Inhibition of phorbol ester-induced T cell proliferation by bryostatin is associated with rapid degradation of protein kinase C. Isakov N, Galron D, Mustelin T, Pettit GR, Altman A. J Immunol; 1993 Feb 15; 150(4):1195-204. PubMed ID: 8432975 [Abstract] [Full Text] [Related]
15. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Arita Y, Buffolino P, Coppock DL. Exp Cell Res; 1998 Aug 01; 242(2):381-90. PubMed ID: 9683525 [Abstract] [Full Text] [Related]
16. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells. Bradshaw TD, Gescher A, Pettit GR. Int J Cancer; 1992 Apr 22; 51(1):144-8. PubMed ID: 1563835 [Abstract] [Full Text] [Related]
17. Altered function of protein kinase C and cyclic adenosine monophosphate-dependent protein kinase in a cell line derived from a mouse lung papillary tumor. Nicks KM, Droms KA, Fossli T, Smith GJ, Malkinson AM. Cancer Res; 1989 Sep 15; 49(18):5191-8. PubMed ID: 2548715 [Abstract] [Full Text] [Related]
18. Protein kinase C isoform delta is involved in the stimulation of the Na(+)-H+ exchanger in C6 glioma cells. Chen CC, Wu ML. Mol Pharmacol; 1995 Dec 15; 48(6):995-1003. PubMed ID: 8848016 [Abstract] [Full Text] [Related]
19. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells. Basu A, Weixel K, Saijo N. Cell Growth Differ; 1996 Nov 15; 7(11):1507-12. PubMed ID: 8930400 [Abstract] [Full Text] [Related]